TOB1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.78723702504158E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.43830003462853E-09 |
Normal-vs-Stage2 |
1.49130000015596E-07 |
Normal-vs-Stage3 |
1.62725388719309E-12 |
Normal-vs-Stage4 |
1.62447832963153E-12 |
Stage1-vs-Stage2 |
5.403600E-01 |
Stage1-vs-Stage3 |
2.72069999862623E-09 |
Stage1-vs-Stage4 |
1.63025148935958E-12 |
Stage2-vs-Stage3 |
2.196300E-02 |
Stage2-vs-Stage4 |
8.163400E-04 |
Stage3-vs-Stage4 |
1.166020E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.10591569025109E-13 |
Normal-vs-AfricanAmerican |
1.78829999997188E-06 |
Normal-vs-Asian |
2.989600E-01 |
Caucasian-vs-AfricanAmerican |
2.392100E-02 |
Caucasian-vs-Asian |
2.095800E-01 |
AfricanAmerican-vs-Asian |
4.395600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.82773804372027E-13 |
Normal-vs-Female |
1.64349978071243E-10 |
Male-vs-Female |
1.189760E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.11539999458898E-09 |
Normal-vs-Age(41-60Yrs) |
4.26525481600493E-12 |
Normal-vs-Age(61-80Yrs) |
3.88755694302745E-12 |
Normal-vs-Age(81-100Yrs) |
7.94040000000606E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.367400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.464400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.201000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.022600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.401800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.003600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
9.583900E-03 |
Normal-vs-Grade 2 |
5.70850000602974E-09 |
Normal-vs-Grade 3 |
1.63469238145808E-12 |
Normal-vs-Grade 4 |
<1E-12 |
Grade 1-vs-Grade 2 |
7.651000E-01 |
Grade 1-vs-Grade 3 |
5.325800E-02 |
Grade 1-vs-Grade 4 |
1.147720E-02 |
Grade 2-vs-Grade 3 |
3.34159999670902E-08 |
Grade 2-vs-Grade 4 |
7.90800758210253E-12 |
Grade 3-vs-Grade 4 |
7.343800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.149299792644E-10 |
Normal-vs-ccB subtype |
2.20101714631937E-12 |
ccA subtype-vs-ccB subtype |
6.420400E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.76680933509033E-13 |
Normal-vs-N1 |
8.47100167788994E-14 |
N0-vs-N1 |
1.071870E-02 |
|
|